Senate Panel Clears Dr. Erica Schwartz for CDC Director Role Despite Science Independence Concerns

A Senate committee voted Thursday to advance Dr. Erica Schwartz’s nomination as director of the Centers for Disease Control and Prevention, moving her closer to confirmation despite lingering questions about her willingness to resist political interference. The 54-year-old physician holds medical and law degrees, served as deputy surgeon general, and held a leadership role at the U.S. Coast Guard. If confirmed by the full Senate, she would become the 22nd director of the Atlanta-based agency tasked with safeguarding Americans from preventable health threats.

Schwartz faced considerable skepticism during her July hearing before the Senate Health, Education, Labor and Pensions Committee, particularly regarding whether she would challenge directives from Trump health secretary Robert F. Kennedy Jr. if they conflicted with scientific evidence and sound public health practice. Committee Chairman Sen. Bill Cassidy, R-La., said he spoke with Schwartz after the hearing and expressed confidence in her commitment to scientific integrity. “I’m confident that she knows what she is doing and will stand against those who do not,” Cassidy stated, lending crucial support needed to move the nomination forward.

Sen. Bernie Sanders of Vermont opposed the nomination, arguing the central question was straightforward: whether Trump administration officials possessed the courage to reject anti-science positions and conspiracy theories. The committee’s largely party-line vote Thursday allowed Schwartz’s nomination to proceed to the full Senate.

Public health experts and organizations expressed reservations about Schwartz’s testimony, particularly her vague responses to questions about protecting CDC independence from political pressure. The National Public Health Coalition, comprised of current and former CDC employees, said her commitments lacked specificity and called on senators to secure written guarantees regarding scientific independence and evidence-based vaccine policy. During the hearing, Schwartz acknowledged unfamiliarity with CDC program cutbacks targeting smoking prevention and vaccination promotion but declined to commit to removing a CDC webpage linking vaccines to autism.

The CDC has undergone significant turmoil since Trump returned to office, losing more than 3,000 employees—representing over one-quarter of its workforce—through layoffs and resignations. The agency has cycled through multiple temporary leaders while staffing the front office with political appointees lacking medical or public health credentials.

Schwartz represents the third Trump nominee for the CDC directorship within 18 months. Dr. David Weldon, a former Florida congressman, had his Senate hearing canceled in March 2025 after insufficient support materialized. Susan Monarez, who served as acting director, was confirmed but removed after less than a month when administration officials deemed her misaligned with the president’s agenda. Multiple HHS officials have since filled the acting director position.